Cadus Pharmaceutical Corp. (KDUS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)

KDUS 1.600

0.0%

Jul 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: FlatTaxMan who wrote (7)	12/3/1998 11:35:00 PM
From: Dave K	Read Replies (1) of 1833

Cadus Pharmaceutical Identifies Ligands for Human Orphan Receptor - Validation of Cadus' SSCL(TM) Reported in Nature Biotechnology - biz.yahoo.com "Christine Klein, Ph.D., primary author of the paper, used a proprietary Cadus technology, the Self-Selecting Combinatorial Library (SSCL™), to screen for the peptide surrogate ligands for FPRL-1. The surrogate ligands which were identified by the SSCL were tested against human cells that express the FPRL-1 receptor and the results suggest that the FPRL-1 receptor plays a role in the body's inflammatory response."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next